← Back to catalogue

Progesterone, 17 a-Hydroxy- (Neonate) (MW) ELISA

FDA UDI

Class I (US FDA UDI)

by DRG Instruments Gesellschaft mit beschränkter Haftung

Identity

Trade Name
Progesterone, 17 a-Hydroxy- (Neonate) (MW) ELISA FDA UDI
Generic Name
17-Hydroxyprogesterone IVD, kit, chemiluminescent immunoassay FDA UDI
Device Name
The quantitative determination of 17-hydroxyprogesterone concentration in human whole blood by a microplate enzyme immunoassay, colorimetric. FDA UDI
Model / Reference
EIA-1429 FDA UDI
Description
The quantitative determination of 17-hydroxyprogesterone concentration in human whole blood by a microplate enzyme immunoassay, colorimetric. FDA UDI

Identifiers

Catalog Number
EIA-1429 FDA UDI
Primary DI / UDI-DI
04048474014297 FDA UDI
FDA Product Code
JLX FDA UDI
GMDN Term
17-Hydroxyprogesterone IVD, kit, chemiluminescent immunoassay FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1395 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: 17-Hydroxyprogesterone IVD, kit, chemiluminescent immunoassay

Progesterone, 17 a-Hydroxy- (Neonate) (MW) ELISA by DRG Instruments Gesellschaft mit beschränkter Haftung — Class I — FDA UDI — listed in FDA GUDID

Similar devices

Also classified as 17-Hydroxyprogesterone IVD, kit, chemiluminescent immunoassay.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 92d09328-8acd-47ed-9188-243e00f0bfd6 36 fields · synced May 30, 2026